NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States Languages English Remove constraint Languages: English

Search Results

7222. Esketamine for the treatment of treatment-resistant depression: effectiveness and value : final evidence report

7223. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary

7224. Tezepelumab for severe asthma: final report

7225. Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report

7226. Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report

7228. Aducanumab for Alzheimer’s disease: effectiveness and value